December 1st, 2010
Study Links Tricyclic Antidepressants to Increased Risk for CVD
Larry Husten, PHD
A survey from Scotland has found an increased risk for cardiovascular disease in people taking tricyclic antidepressants (TCAs). In an article in the European Heart Journal, the researchers write that they failed to find any increased risk with selective serotonin reuptake inhibitors (SSRIs). Nearly 15,000 Scottish adults without known histories of CVD were followed for 8 […]
NEJM Journal Watch — Recent Cardiology Articles- Is Diltiazem Safe in Patients with AF Taking Apixaban or Rivaroxaban?
- Does Lowering High Childhood Lipid Levels Prevent Adverse Cardiovascular Events in Adulthood?
- Self-Expanding Supraannular Valve vs. Balloon-Expandable Valve in TAVR for Small Aortic Annulus
- A New TAVR Prosthesis for Aortic Regurgitation Shows Promise
- Aprocitentan, a Newly Approved Drug for Resistant Hypertension